Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression

Clinical Immunology

Volumn 141, Issue 3, 2011, Pages 317-327

  Hofmann, S R ^a   Schwarz, T ^b   Moller J C ^a   Morbach, H ^b   Schnabel, A ^a   Rosen Wolff A ^a   Girschick, H J ^c   Hedrich, C M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

Author keywords

Chromatin; CNO; IL 10; Inflammation; Osteomyelitis; Sp1

Indexed keywords

HISTONE H3; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; SERINE; TRANSCRIPTION FACTOR SP1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CHRONIC NONBACTERIAL OSTEOMYELITIS; CHRONIC OSTEOMYELITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIGENETICS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HETEROZYGOSITY; HISTONE PHOSPHORYLATION; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MONOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELLS, CULTURED; CHRONIC DISEASE; CYTOKINES; HISTONES; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; OSTEOMYELITIS; PHOSPHORYLATION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SP1 TRANSCRIPTION FACTOR;

EID: 81355148841     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.08.012     Document Type: Article

References (50)

1. Morbach H., Dick A., Beck C., Stenzel M., Müller-Hermelink H.K., Raab P., Girschick H.J. Association of chronic non-bacterial osteomyelitis with Crohn's disease but not with CARD15 gene variants. Rheumatol. Int. 2010, 30(5):617-621.
2. Girschick H.J., Raab P., Surbaum S., Trusen A., Kirschner S., Schneider P., Papadopoulos T., Müller-Hermelink H.K., Lipsky P.E. Chronic non-bacterial osteomyelitis in children. Ann. Rheum. Dis. 2005, 64(2):279-285.
3. Giedion A., Holthusen W., Masel L.F., Vischer D. Subacute and chronic "symmetrical" osteomyelitis. Ann. Radiol. (Paris) 1972, 15(3):329-342.
4. Björkstén B., Gustavson K.H., Eriksson B., Lindholm A., Nordström S. Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J. Pediatr. 978, 93(2):227-231.
5. Jurik A.G. Chronic recurrent multifocal osteomyelitis. Semin. Musculoskelet. Radiol. 2004, 8(3):243-253.
6. Huber A.M., Lam P.Y., Duffy C.M., Yeung R.S., Ditchfield M., Laxer D., Cole W.G., Kerr Graham H., Allen R.C., Laxer R.M. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J. Pediatr. 2002, 141(2):198-203.
7. Schultz C., Holterhus P.M., Seidel A., Jonas S., Barthel M., Kruse K., Bucsky P. Chronic recurrent multifocal osteomyelitis in children. Pediatr. Infect. Dis. J. 1999, 18(11):1008-1013.
8. Laxer R.M., Shore A.D., Manson D., King S., Silverman E.D., Wilmot D.M. Chronic recurrent multifocal osteomyelitis and psoriasis-a report of a new association and review of related disorders. Semin. Arthritis Rheum. 1988, 17(4):260-270.
9. Job-Deslandre C., Krebs S., Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Joint Bone Spine 2001, 68(3):245-251.
10. Girschick H.J., Huppertz H.I., Harmsen D., Krauspe R., Müller-Hermelink H.K., Papadopoulos T. Chronic recurrent multifocal osteomyelitis in children: diagnostic value of histopathology and microbial testing. Hum. Pathol. 1999, 30(1):59-65.
11. Gikas P.D., Islam L., Aston W., Tirabosco R., Saifuddin A., Briggs T.W., Cannon S.R., O'Donnell P., Jacobs B., Flanagan A.M. Nonbacterial osteitis: a clinical, histopathological, and imaging study with a proposal for protocol-based management of patients with this diagnosis. J. Orthop. Sci. 2009, 14(5):505-516.
12. King S.M., Laxer R.M., Manson D., Gold R. Chronic recurrent multifocal osteomyelitis: a noninfectious inflammatory process. Pediatr. Infect. Dis. J. 1987, 6(10):907-911.
13. Hamel J., Paul D., Gahr M., Hedrich C.M. Pilot study: possible association of IL10 promoter polymorphisms with CRMO. Rheumatol. Int. 2011, [Electronic publication ahead of print].
14. Kastner D.L. Hereditary periodic fever syndromes. Hematology Am. Soc. Hematol. Educ. Program 2005, 74-81.
15. Golla A., Jansson A., Ramser J., Hellebrand H., Zahn R., Meitinger T., Belohradsky B.H., Meindl A. Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22. Eur. J. Hum. Genet. 2002, 10(3):217-221.
16. Hedrich C.M., Bream J.H. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol. Res. 2010, 47(1-3):185-206.
17. Brenner C., Fuks F. A methylation rendezvous: reader meets writers. Dev. Cell 2007, 12(6):843-844.
18. Eskdale J., Wordsworth P., Bowman S., Field M., Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997, 49(6):635-639.
19. Lazarus R., Vercelli D., Palmer L.J., Klimecki W.J., Silverman E.K., Richter B., Riva A., Ramoni M., Martinez F.D., Weiss S.T., Kwiatkowski D.J. Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol. Rev. 2002, 190:9-25.
20. Vicari A.P., Trinchieri G. Interleukin-10 in viral diseases and cancer: exiting the labyrinth?. Immunol. Rev. 2004, 202:223-236.
21. Sanchez R., Levy E., Costea F., Sinnett D. IL-10 and TNF-alpha promoter haplotypes are associated with childhood Crohn's disease location. World J. Gastroenterol. 2009, 15(30):3776-3782.
22. Koss K., Satsangi J., Fanning G.C., Welsh K.I., Jewell D.P. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun. 2000, 1(3):185-190.
23. Möller J.C., Paul D., Ganser G., Range U., Gahr M., Kelsch R., Rösen-Wolff A., Hedrich C.M. IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). Clin. Exp. Rheumatol. 2010, 28(6):912-918.
24. Gibson A.W., Edberg J.C., Wu J., Westendorp R.G., Huizinga T.W., Kimberly R.P. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 2001, 166(6):3915-3922.
25. Mörmann M., Rieth H., Hua T.D., Assohou C., Roupelieva M., Hu S.L., Kremsner P.G., Luty A.J., Kube D. Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun. 2004, 5(4):246-255.
26. Salhi A., Rodrigues V., Santoro F., Dessein H., Romano A., Castellano L.R., Sertorio M., Rafati S., Chevillard C., Prata A., Alcaïs A., Argiro L., Dessein A. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J. Immunol. 2008, 180(9):6139-6148.
27. Reuss E., Fimmers R., Kruger A., Becker C., Rittner C., Höhler T. Differential regulation of interleukin-10 production by genetic and environmental factors-a twin study. Genes Immun. 2002, 3(7):407-413.
28. Hedrich CM, Tsokos GC. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. TMM 2011, in press [Electronic publication ahead of print].
29. Zhang X., Edwards J.P., Mosser D.M. Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J. Immunol. 2006, 177(2):1282-1288.
30. Brightbill H.D., Plevy S.E., Modlin R.L., Smale S.T. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 2000, 164(4):1940-1951.
31. Ma W., Lim W., Gee K., Aucoin S., Nandan D., Kozlowski M., Diaz-Mitoma F., Kumar A. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 2001, 276(17):13664-13674.
32. Steinke J.W., Barekzi E., Hagman J., Borish L. Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by sp1. J. Immunol. 2004, 173(5):3215-3222.
33. Lucas M., Zhang X., Prasanna V., Mosser D.M. ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J. Immunol. 2005, 175(1):469-477.
34. Chanteux H., Guisset A.C., Pilette C., Sibille Y. LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms. Respir. Res. 2007, 8:71.
35. Norkina O., Dolganiuc A., Shapiro T., Kodys K., Mandrekar P., Szabo G. Acute alcohol activates STAT3, AP-1, and Sp-1 transcription factors via the family of Src kinases to promote IL-10 production in human monocytes. J. Leukoc. Biol. 2007, 82(3):752-762.
36. Vega M.I., Huerta-Yepaz S., Garban H., Jazirehi A., Emmanouilides C., Bonavida B. Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: pivotal role of p38 MAPK in drug resistance. Oncogene 2004, 23(20):3530-3540.
37. Platzer C., Fritsch E., Elsner T., Lehmann M.H., Volk H.D., Prösch S. Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur. J. Immunol. 1999, 29(10):3098-3104.
38. Brenner S., Prösch S., Schenke-Layland K., Riese U., Gausmann U., Platzer C. cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J. Biol. Chem. 2003, 278(8):5597-5604.
39. Berg D.J., Kühn R., Rajewsky K., Müller W., Menon S., Davidson N., Grünig G., Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 1995, 96(5):2339-2347.
40. Siewe L., Bollati-Fogolin M., Wickenhauser C., Krieg T., Müller W., Roers A. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA. Eur. J. Immunol. 2006, 36(12):3248-3255.
41. Ranatunga D., Hedrich C.M., Wang F., McVicar D.W., Nowak N., Joshi T., Feigenbaum L., Grant L.R., Stäger S., Bream J.H. A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(40):17123-17128.
42. Parameswaran N., Patial S. Tumor necrosis factor-α signaling in macrophages. Crit. Rev. Eukaryot. Gene Expr. 2010, 20(2):87-103.
43. Sethu S., Melendez A.J. New developments on the TNFα-mediated signalling pathways. Biosci. Rep. 2010, 31(1):63-76.
44. Eleftheriou D., Gerschman T., Sebire N., Woo P., Pilkington C.A., Brogan P.A. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology (Oxford) 2010, 49(8):1505-1512. Epub 2010 Apr 29.
45. Wilson J.N., Rockett K., Keating B., Jallow M., Pinder M., Sisay-Joof F., Newport M., Kwiatkowski D. A hallmark of balancing selection is present at the promoter region of interleukin 10. Genes Immun. 2006, 7(8):680-683.
46. Oleksyk T.K., Shrestha S., Truelove A.L., Goedert J.J., Donfield S.M., Phair J., Mehta S., O'Brien S.J., Smith M.W. Extended IL10 haplotypes and their association with HIV progression to AIDS. Genes Immun. 2009, 10(4):309-322.
47. Franke A., Balschun T., Karlsen T.H., Sventoraityte J., Nikolaus S., Mayr G., Domingues F.S., Albrecht M., Nothnagel M., Ellinghaus D., Sina C., Onnie C.M., Weersma R.K., Stokkers P.C., Wijmenga C., Gazouli M., Strachan D., McArdle W.L., Vermeire S., Rutgeerts P., Rosenstiel P., Krawczak M., Vatn M.H., Mathew C.G., Schreiber S. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 2008, 40(11):1319-1323. IBSEN study group.
48. Tone M., Powell M.J., Tone Y., Thompson S.A., Waldmann H. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J. Immunol. 2000, 165(1):286-291.
49. Hedrich CM, Bruck N, Paul D; Hahn G, Gahr M., Roesen-Wolff A. Mutation negative Familial Cold Autoinflammatory Syndrome (FCAS) in an 8-year-old boy - Clinical course and functional studies. Rheumatol Int. in press [Electronic publication ahead of print].
50. Zhao Z., Li Y., Li Y., Zhao H., Li H. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with review of the relevant published work. J. Dermatol. 2011, 38(2):155-159.